Can Ablation Prevent the Excess Mortality of Atrial Fibrillation?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The relative merits of rate and rhythm control in the treatment of patients with atrial fibrillation have been compared in several major clinical trials, none of which demonstrated a significant difference in all-cause mortality. Yet, there is clear evidence that restoration and maintenance of sinus rhythm is associated with beneficial reverse atrial remodeling. These apparently contradictory findings may reflect the combination of serious adverse effects coupled with limited efficacy of currently available antiarrhythmic drugs, counterbalancing their beneficial effect in restoring sinus rhythm. Catheter ablation offers an alternative means of restoring sinus rhythm in patients with atrial fibrillation, and several clinical trials have indicated its superior outcomes and improved benefit/risk profile. Ongoing trials will soon determine its overall impact on survival.
- American Heart Association: Heart Disease and Stroke Statistics: 2005 Update. Dallas, TX: American Heart Association; 2005.
- Wyse DG, Waldo AL, DiMarco JP, et al.: A comparison of rate control and rhythm control in patients with AF. N Engl J Med 2002, 347:1825–1833. CrossRef
- Van Gelder IC, Hagens VE, Bosker HA, et al.: A comparison of rate control and rhythm control in patients with recurrent persistent AF. N Engl J Med 2002, 347:1834–1840. CrossRef
- Opolski G, Torbicki A, Kosior DA, et al.: Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004,126:476–486. CrossRef
- Hohnloser SH, Kuck KH, Lilienthal J: Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000, 356:1789–1794. CrossRef
- Carlsson J, Miketic S, Windeler J, et al.: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003, 41:1690–1696. CrossRef
- Pederson OD, Bagger H, Keller N, et al.: Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy. Circulation 2001, 104:292–296.
- Corley SD, Epstein AE, DiMarco JP, et al.: Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109:1509–1513. CrossRef
- Stabile G, Bertaglia E, Senatore G, et al.: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study). Eur Heart J 2006, 27:216–221. CrossRef
- Jais P, Cauchemez B, Macle L, et al.: Atrial fibrillation ablation versus antiarrhythmic drugs: a multicentre randomized trial. Program and abstracts from Heart Rhythm Society 2006 Annual Scientific Sessions. Boston, MA; May 17–20, 2006.
- Pappone C, Augello G, Sala S, et al.: A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol 2006, 48:2340–2347. CrossRef
- Oral H, Pappone C, Chugh A, et al.: Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006, 354:934–941. CrossRef
- Wazni OM, Marrouche NF, Martin DO, et al.: Radiofrequency ablation versus antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. A randomized trial. JAMA 2005, 293:2634–2640. CrossRef
- Can Ablation Prevent the Excess Mortality of Atrial Fibrillation?
Current Cardiology Reports
Volume 12, Issue 5 , pp 389-392
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Atrial fibrillation
- Antiarrhythmic drug
- Catheter ablation
- Sinus rhythm
- Industry Sectors